Translation. Region: Russian Federal
Source: Peter the Great St. Petersburg Polytechnic University –
An important disclaimer is at the bottom of this article.
Scientists from Peter the Great St. Petersburg Polytechnic University, together with colleagues from the A. A. Smorodintsev Research Institute of Influenza of the Russian Ministry of Health, have obtained recombinant interferon-lambda, known as type 3 interferon, in laboratory conditions. It protects humans from viral infections and at the same time has a number of advantages over type 1 and type 2 interferons. About this reports RIA Novosti.
Interferons are proteins that are produced in response to viral invasion and prevent their reproduction. Lambda interferons act locally, mainly on the mucous membrane of the respiratory tract, without causing excessive activation of the immune system and serious side effects characteristic of alpha interferons.
According to experts, experiments have shown the effectiveness of the new drug not only for prevention, but also for treatment at an early stage of the disease, as well as for secondary infections.
At the same time, scientists warn that in the acute phase of the disease, interferons, especially the first type, should be used with caution.
The research team plans to create a drug in the form of nasal drops or spray.
Read more Here.
Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.
.